Modeling potential cost-effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity.
Saved in:
| Title: | Modeling potential cost-effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity. |
|---|---|
| Authors: | Hoog MM; Eli Lilly and Company, Indianapolis, Indiana, USA., Kan H; Eli Lilly and Company, Indianapolis, Indiana, USA., Deger KA; Evidera Inc., Wilmington, North Carolina, USA., Sorensen S; Evidera Inc., Wilmington, North Carolina, USA., Neff LM; Eli Lilly and Company, Indianapolis, Indiana, USA., Bae JP; Eli Lilly and Company, Indianapolis, Indiana, USA., Hankosky ER; Eli Lilly and Company, Indianapolis, Indiana, USA., Murphy M; Eli Lilly and Company, Indianapolis, Indiana, USA., Mojdami D; Eli Lilly and Company, Indianapolis, Indiana, USA., Houisse I; Evidera Inc., Wilmington, North Carolina, USA.; Evidera, Budapest, Hungary., Harris MS; Evidera Inc., Wilmington, North Carolina, USA. |
| Source: | Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2025 Jul; Vol. 33 (7), pp. 1297-1308. Date of Electronic Publication: 2025 Jun 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101264860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1930-739X (Electronic) Linking ISSN: 19307381 NLM ISO Abbreviation: Obesity (Silver Spring) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
